2 Medtronic’s Infuse Patients To Get $8.45 Million in Settlements

Patients who received Medtronic’s Infuse product to get $8.45 million in settlements

https://www.startribune.com/patients-who-received-medtronic-product-to-get-8-45-million-in-settlements/388947831/Two patients who were injured by Medtronic’s controversial Infuse bone graft product will receive a combined $8.45 million in settlements with the University of California Los Angeles, where a doctor with financial ties to the company used the product …

Original report

Medtronic Disentangles From Durrani Infuse Lawsuits

https://ryortho.com/breaking/medtronic-disentangles-from-durrani-infuse-lawsuits/Spine patients in Ohio who had back surgery performed by federal fugitive, Atiq Durrani M.D., joined together to sue Medtronic because Durrani used Infuse in an alleged off-label fashion.

Durrani is currently practicing back surgery on Pakistanis after …

Original report

Regents OK $8.5 million for 2 patients suing over financial conflicts

https://www.latimes.com/business/la-fi-ucla-wang-medtronics-20160729-snap-story.htmlThe University of California regents have agreed to pay nearly $8.5 million to settle two lawsuits alleging that a well-known UCLA spine surgeon failed to …

Original report

In letter to Franken, FDA defends handling of Medtronic’s Infuse study

https://www.startribune.com/in-letter-to-franken-fda-defends-handling-of-medtronic-s-infuse-study/384052101/After receiving the FDA’s response to his questions, Franken says the handling of Medtronic’s Infuse study signals a broader need to change how the agency safeguards the public’s health.

He called for “a more robust, proactive medical device …

Original report

Sen. Franken pushes for review of Medtronic Infuse study

https://www.massdevice.com/sen-franken-pushes-review-medtronic-infuse-study/Medtronic InFuse Senator Al Franken (D-Minn.) is pushing for more details on Medtronic’s (NYSE:MDT) study of its Infuse Bone Graft, saying that the product …

Original report


Please follow and like us:

Leave a Reply

Your email address will not be published. Required fields are marked *